International Immunopharmacology

International Immunopharmacology is a subscription (hybrid open access) journal published by Elsevier BV in the Netherlands. OpenAlex counts 16,851 works from it, cited 452,712 times; its h-index is 177. Its two-year mean citedness, which is computed the way the impact factor is, is 6.03: a paper it published in the two years before was cited about 6.03 times last year. It published 1,963 papers in 2025, down 14% from 2,290 in 2024. Publishing a paper open access in it costs about US$3,220.

Publisher
Elsevier BV
Citations per paper
6.03 two-year mean, OpenAlex
h-index
177 i10-index 10,487
Access
Subscription · hybrid open access
APC
US$3,220 to publish open access
ISSN
1567-5769, 1878-1705
Country
Netherlands
Works published
16,851 cited 452,712 times
Papers in 2025
1,963
Field
Immunology and Microbiology
Website
Journal home ↗

International Immunopharmacology year by year

Papers it published each year, and the citations all its papers received that year.

YearPapers publishedCitations received
2026 so far1,42064,528
20251,96365,366
20242,29052,333
20231,66141,857
20221,05339,220
20211,06233,187
20201,09224,590
201972717,641

What International Immunopharmacology publishes

Its most frequent research topics, by OpenAlex's topic classification.

Questions about International Immunopharmacology

What is the impact factor of International Immunopharmacology?

Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 6.03 for International Immunopharmacology: on average, each paper it published in the two years before was cited about 6.03 times in a year.

What is the h-index of International Immunopharmacology?

177, by OpenAlex's count: 177 of its papers have each been cited at least 177 times. Its i10-index is 10,487.

Is International Immunopharmacology open access?

Not fully. International Immunopharmacology is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.

What is the publication fee (APC) of International Immunopharmacology?

About US$3,220, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.

What is the ISSN of International Immunopharmacology?

Its linking ISSN is 1567-5769; all its ISSNs: 1567-5769, 1878-1705.

Who publishes International Immunopharmacology?

Elsevier BV, based in the Netherlands.

How many papers does International Immunopharmacology publish a year?

1,963 in 2025, by OpenAlex's count of what it published that year.

What does International Immunopharmacology publish?

Its most frequent research topics are Natural Compounds in Disease Treatment, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, in the field of Immunology and Microbiology.

Is International Immunopharmacology a predatory journal?

Nothing in the scholarly indexes suggests so. International Immunopharmacology is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 16,851 works cited 452,712 times. For a journal you do not know, check the red flags with our predatory journal checker.

Is International Immunopharmacology indexed in Scopus or Web of Science?

Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1567-5769): both are free to search. Our guide on checking journal indexing shows each step.

Journals like International Immunopharmacology

Other Immunology and Microbiology journals with a similar impact.

Every Immunology and Microbiology journal, ranked · The journal directory

Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).